![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/sound-pharma-to-present-positive-interim-data-from-its-phase-2b-cystic-fibrosis-stop-ototoxicity-trial-302047678.html
https://www.prnewswire.com/news-releases/sound-pharma-initiates-enrollment-in-pivotal-phase-3-clinical-trial-of-spi-1005-for-the-treatment-of-hearing-loss-and-tinnitus-in-menieres-disease-301595208.html
https://www.prnewswire.com/news-releases/sound-pharmaceuticals-nih-grant-for-a-novel-oral-covid-19-treatment-increases-to-4-2m-301545041.html
https://www.clinicaltrialsarena.com/news/sound-oral-therapeutic-trial/
https://www.prnewswire.com/news-releases/sound-pharmaceuticals-awarded-3-1m-nih-grant-to-test-spi-1005-in-covid-19--301262987.html
https://www.contractpharma.com/contents/view_breaking-news/2021-04-06/sound-pharmaceuticals-receives-31m-nih-grant-for-covid-treatment/?widget=listSection
https://www.biospace.com/article/releases/fda-allows-sound-pharmaceuticals-to-test-spi-1005-as-a-novel-treatment-for-covid-19/
https://www.prnewswire.com/news-releases/sound-pharmaceuticals-files-ind-to-test-spi-1005-in-phase-2-covid-19-trials-301103291.html